Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$169K Buy
2,744
+970
+55% +$64.3K 0.02% 464
2024
Q4
$128K Sell
1,774
-93
-5% -$7.26K 0.01% 488
2024
Q3
$152K Buy
1,867
+66
+4% +$5.28K 0.01% 451
2024
Q2
$134K Buy
1,801
+5
+0.3% +$375 0.01% 451
2024
Q1
$140K Buy
1,796
+10
+0.6% +$744 0.01% 442
2023
Q4
$128K Buy
1,786
+255
+17% +$17.8K 0.01% 452
2023
Q3
$106K Sell
1,531
-13
-0.8% -$982 0.01% 451
2023
Q2
$125K Buy
1,544
+6
+0.4% +$490 0.01% 430
2023
Q1
$124K Sell
1,538
-73
-5% -$5.88K 0.01% 426
2022
Q4
$121K Buy
1,611
+69
+4% +$4.91K 0.01% 444
2022
Q3
$99K Sell
1,542
-32
-2% -$2.22K 0.02% 430
2022
Q2
$109K Buy
1,574
+33
+2% +$2.45K 0.02% 425
2022
Q1
$118K Sell
1,541
-47
-3% -$3.38K 0.02% 414
2021
Q4
$122K Buy
1,588
+64
+4% +$4.7K 0.02% 443
2021
Q3
$112K Hold
1,524
0.03% 248
2021
Q2
$102K Sell
1,524
-68
-4% -$4.55K 0.02% 290
2021
Q1
$118K Buy
1,592
+41
+3% +$3.11K 0.03% 244
2020
Q4
$113K Buy
1,551
+9
+0.6% +$635 0.03% 222
2020
Q3
$102K Buy
1,542
+28
+2% +$1.77K 0.03% 201
2020
Q2
$86K Buy
1,514
+53
+4% +$2.6K 0.03% 240
2020
Q1
$51K Buy
1,461
+581
+66% +$27.7K 0.02% 317
2019
Q4
$46K Hold
880
0.02% 473
2019
Q3
$44K Hold
880
0.02% 465
2019
Q2
$42K Hold
880
0.02% 469
2019
Q1
$42K Hold
880
0.02% 470
2018
Q4
$36K Buy
+880
New +$36.1K 0.02% 442

Other funds holding HOLX

Lindbrook Capital's HOLX Position: Q1 2025 in Review

Lindbrook Capital increased its Hologic (HOLX) stake by 55% in Q1 2025, buying an estimated $64.3K and bringing the position to 2,744 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #464.

Lindbrook Capital first reported a position in HOLX in Q4 2018 and has held it in 26 quarters since. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Lindbrook Capital held 2,744 shares of Hologic worth $169K as of Q1 2025.
  • Lindbrook Capital bought 970 Hologic shares in Q1 2025, an estimated $64.3K.
  • Hologic made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #464 holding.
  • Lindbrook Capital first reported a position in Hologic in Q4 2018 and has held it in 26 quarters since.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.